the Scripps Research Translational Institute
Johnson & Johnson
iRhythm Technologies'
American Heart Association Scientific Sessions
AF
Peerfit
The Tampa Bay Business Journal
Exits & Outcomes
Peloton Interactive
SEC
SimpleSENSE
FDA
onPoint Oncology
Connected
the Vitals Data Service
Zio
Peloton
Peerfit
Nanowear
Venk Varadan
RxVantage
Dan Gilman
Jiang Li
Suci Arumsari
Alodokter
Luscii
HIMSS MediaMobiHealthNews
No matching tags
No matching tags
No matching tags
The company is commercializing the product with "select channel partners," and also said that it is conducting a clinical trial measuring the wearable's use in diagnosing worsening heart failure and COVID-19."SimpleSENSE marks the company's second FDA 510(k) clearance and follows Nanowear's strategy of continued data-driven differentiation in the connected-care and remote diagnostic market," Venk Varadan, cofounder and CEO of Nanowear, said in a statement.
As said here by https://www.mobihealthnews.com/news/results-3-year-zio-patch-study-pelotons-apparent-peerfit-purchases-and-more-digital-health-news